Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03965494 |
Title | AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Comprehensive Cancer Center at University of Alabama at Birmingham | Birmingham | Alabama | 35294 | United States | Details | |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | 21231 | United States | Details | |
Henry Ford Hospital | Detroit | Michigan | 48202 | United States | Details | |
Memorial Sloan Kettering | New York | New York | 10065 | United States | Details | |
Wake Forest University Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157 | United States | Details | |
University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details |